Refine by MP, party, committee, province, or result type.

Results 1-15 of 262
Sort by relevance | Sorted by date: newest first / oldest first

Health committee  Thank you, Madam Chair. Hon. members of Parliament, I appreciate the opportunity to bring the perspective of the Canadian Institutes of Health Research to your study of health human resources. CIHR is the Government of Canada's agency responsible for the funding of health resea

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  I'm happy to take it. Your question is a very interesting one. I think it reflects the huge changes in society. You remember that until 1999, our agency was called the Medical Research Council. It is now called the Canadian Institutes of Health Research. I think this shift in f

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  I would simply like to make a brief comment. You are perfectly right. This is a matter which, when it comes to health care, is clearly under provincial jurisdiction. If we want to conduct effective clinical research in health services, epidemiology in particular, we have no choi

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  You're right, and as I said at the beginning, it's fully part of our mandate not only to create new knowledge, but to ensure that it is properly translated into better health and better health care. And quite frankly, I think we haven't delivered as well on the second part, and i

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  It is a difficult question, but then I love to dream in technicolor, so I'll have a shot at it. I would say break the silos. Again, it's very much from the perspective of research-based practice, and to me it's a practice that uses the levers of research. Break the silos between

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  It's very important. I think it's critical if you want to actually bring the research and the practice into practice, because otherwise you'll never have the respect of where the research comes from. The second point is that everything we do should be in terms of building in me

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  Yes; it's about time. Let's make sure from the start that these will be built in such a way that they will be accessible for research purposes, and that the question of protection of personal information is ensured from the start, so that we're not told in ten years that we can

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  Now then, the first part of your question refers more or less to what you just asked regarding the breadth of vision. With regard to research, we are talking about competitiveness at the national level, about combining our resources and establishing uniform standards of practice

April 23rd, 2009Committee meeting

Alain Beaudet

Health committee  Thank you, Madam Chair. I'm pleased to appear before you as part of the review of Dr. Prigent's recent appointment to the CIHR governing council. Let me tell you right at the outset how much CIHR's governing council and I personally welcome and support this superb addition to ou

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  I can definitely do that. First of all, I would like to go back to the question from your colleague Ms. Bennett. In fact, they are all potentially in conflict of interest. There is a vice-president for research. Is he speaking for his university? Should we have former vice-pres

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Correct.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  First of all, I'd like to reiterate that Dr. Prigent is not representing Pfizer. Actually, if he was representing Pfizer, the outcry wouldn't be from the community; it would be from all the pharmaceutical companies that would also want to have a representative. Dr. Prigent is r

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  First of all, I can only state what I know. I know for a fact that there's a heavy presence in the U.K. on the board of MRC of the biopharmaceutical sector, and I must say that they are fairly successful at curbing the trend and doing things differently in terms of innovation and

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  The letter of support you have is a letter of support by the governing council, signed by all members.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Perhaps the other letter was not distributed. There was a letter written to this committee, I think, sent to you on behalf of all members of the governing council.

November 30th, 2009Committee meeting

Dr. Alain Beaudet